You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 116 No. 6, June 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Case Reports and Small Case Series
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (38)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Electrophysiologic Evaluation of a Patient With Peripheral Visual Field Contraction Associated With Vigabatrin

Arch Ophthalmol. 1998;116:817-819.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Anticonvulsants are known to cause different kinds of visual disturbances.1 Recently, vigabatrin has received attention because of considerable bilateral concentric field defects observed in a few patients receiving this drug as add-on therapy.2 These field constrictions appear to be irreversible in most cases. Surprisingly, only subtle changes of retinal function have been reported, most often alterations of the oscillatory potentials in the electroretinogram (ERG). Findings from histopathological studies in rats, mice, and dogs but not in monkeys and humans show a microvacuolation in myelin sheaths of the white matter when exposed to vigabatrin.3 However, all these alterations cannot sufficiently explain a severe concentric visual field constriction.

Report of a Case

A 17-year-old boy suffered from focal epilepsy of unknown origin since the age of 13. Following unsuccessful treatment with carbamazepine and valproate as monotherapy and polytherapy, he was put on a combination regimen of valproate and vigabatrin 18 months prior to our first examination . . . [Full Text of this Article]


Comment
Corresponding author: Klaus Ruether, MD, Charité-Virchow Augenklinik, Augustenburger Platz 1, 13353 Berlin, Germany (e-mail: ruether@ukrv.de).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Retinal Function Abnormalities in Patients Treated With Vigabatrin
Banin et al.
Arch Ophthalmol 2003;121:811-816.
ABSTRACT | FULL TEXT  

Visual Field Constriction in Children With Epilepsy on Vigabatrin Treatment
Iannetti et al.
Pediatrics 2000;106:838-842.
ABSTRACT | FULL TEXT  

Separating the retinal electrophysiologic effects of vigabatrin: Treatment versus field loss
Harding et al.
Neurology 2000;55:347-352.
ABSTRACT | FULL TEXT  

A controlled study of vigabatrin and visual abnormalities
Manuchehri et al.
Br. J. Ophthalmol. 2000;84:499-505.
ABSTRACT | FULL TEXT  

Vigabatrin associated visual field constriction
ACHESON
J. Neurol. Neurosurg. Psychiatry 1999;67:707-708.
FULL TEXT  

Visual field defects associated with vigabatrin therapy
Lawden et al.
J. Neurol. Neurosurg. Psychiatry 1999;67:716-722.
ABSTRACT | FULL TEXT  

Visual dysfunction in patients receiving vigabatrin: Clinical and electrophysiologic findings
Miller et al.
Neurology 1999;53:2082-2082.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.